Cite
HARVARD Citation
Tiziano, F. et al. (2019). Longitudinal evaluation of SMN levels as biomarker for spinal muscular atrophy: results of a phase IIb double-blind study of salbutamol. Journal of medical genetics. 56 (5), pp. 293-300. [Online].